BEYOND AIR INC. - COM

0,4632

08-ноября-24 15:24:27

15 мин. задержка

Акции

-0,0456

-8,96%

Сегодняшний диапазон

0,4632 - 0,5100

ISIN

N/A

Источник

NASDAQ

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

15 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

13 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

03 ноя 2023 12:00:00 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast

19 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in the Truist Securities BioPharma Symposium

17 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice

17 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

16 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH

16 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

04 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference

02 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting

27 сен 2023 09:00:00 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

18 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference

06 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024

10 авг 2023 16:05:01 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

07 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in BTIG’s 2023 Virtual Biotechnology Conference

01 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023

22 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Secures up to $40 Million Debt Financing

15 июн 2023 16:10:00 Источник Nasdaq GlobeNewswire
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem

15 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

16 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.